Advertisement

Topics

TherapeuticsMD Announces FDA Approval of ANNOVERA™ (Segesterone Acetate/Ethinyl Estradiol Vaginal System) for Birth Control

15:05 EDT 10 Aug 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
The first and only birth control approved as a vaginal system The first and only patient-controlled, procedure-free, long-acting, reversible prescription birth control product to provide a full year of protection from p...

Other Sources for this Article

TherapeuticsMD, Inc.
Investor Contact:
Nichol Ochsner, 561-961-1900, ext. 2088
Vice President Investor Relations
Nochsner@TherapeuticsMD.com

NEXT ARTICLE

More From BioPortfolio on "TherapeuticsMD Announces FDA Approval of ANNOVERA™ (Segesterone Acetate/Ethinyl Estradiol Vaginal System) for Birth Control"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Obstetrics and gynaecology
Fertility Menopause Obstetrics & Gynaecology Osteoporosis Women's Health Obstetrics and gynaecology comprises the care of the pregnant woman, her unborn child and the management of diseases specific to women. Most consultant...